Comment on “Non-Proportional Hazards–an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group

Cross-Pharma Non-proportional Hazards Working Group

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)312-314
Number of pages3
JournalStatistics in Biopharmaceutical Research
Issue number2
StatePublished - 2023
Externally publishedYes

Cite this